Aprea Therapeutics, Inc.

Historical 13F Holders

Symbol
APRE
CUSIP
03836J102
All holders as of
Q2 2025
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Shares Held, Excluding Options
Total Filers

13D/G Filers

Each filer's latest filing for 03836J102 since 12/18/2024, largest first.

Filer % of Class Filed
Squadron Capital Management LLC 13G
9.9% 4/7/2026
Event 3/30/2026
Orin Hirschman 13G/A
9.9% 4/27/2026
Event 3/31/2026
Sio Capital Management, LLC 13G/A 5.1% 2/10/2025
Event 12/31/2024
Under 5%, checked the "5 percent or less" box, or amended by a later filing (1)
Soleus Private Equity Fund III, L.P. 13G
10.0%
Checked 5% or less
4/1/2026
Event 4/1/2026

13F Holders by Quarter

Period Filers Shares, Excl. Options Value, Excl. Options
2025 Q2 1 0 $0
2025 Q1 1 0 $0
2024 Q4 1 0 $0
2024 Q3 2 899 $2.00k
2024 Q2 2 899 $3.00k
2024 Q1 3 999 $675
2023 Q4 2 100 $470
2023 Q3 2 100 $417
2023 Q2 2 100 $315
2023 Q1 3 103 $457
2022 Q4 27 1.59 M $521k
2022 Q3 30 1.71 M $1.11M
2022 Q2 36 2.03 M $1.52M
2022 Q1 42 2.42 M $4.50M
2021 Q4 43 3.61 M $10.4M
2021 Q3 41 5.00 M $25.6M
2021 Q2 51 6.54 M $31.9M
2021 Q1 70 8.93 M $45.4M
2020 Q4 67 10.3 M $50.8M
2020 Q3 65 16.8 M $405M
2020 Q2 65 16.5 M $639M
2020 Q1 51 13.5 M $467M
2019 Q4 40 12.9 M $591M